C 036: IMPACT OF RARE DISEASES IN THE HEALTH POLICIES IN COUNTRIES UNDER DEVELOPMENT. EXPERIENCES AT LATIN-AMERICA AND CARIBBEAN

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S108, 2014 Special supplement with the abstract book of LATINFARMA 2013 Conference C 036: IMPACT OF RARE DISEASES IN THE HEALTH POLICIES IN COUNTRIES UNDER DEVELOPMENT. EXPERIENCES AT LATIN-AMERICA AND CARIBBEAN (LA&C) Llera VA. ICORD/GEISER, Argentina. Abstract The inclusion of the Rare Diseases as a nosology within Public Health … Continue reading C 036: IMPACT OF RARE DISEASES IN THE HEALTH POLICIES IN COUNTRIES UNDER DEVELOPMENT. EXPERIENCES AT LATIN-AMERICA AND CARIBBEAN

J Pharm Pharmacogn Res 2(Suppl. 1): S108, 2014

Special supplement with the abstract book of LATINFARMA 2013

Conference

C 036: IMPACT OF RARE DISEASES IN THE HEALTH POLICIES IN COUNTRIES UNDER DEVELOPMENT. EXPERIENCES AT LATIN-AMERICA AND CARIBBEAN (LA&C)

Llera VA.

ICORD/GEISER, Argentina.
Abstract

The inclusion of the Rare Diseases as a nosology within Public Health was an initiative from the affected citizens living in USA during the 70´s. Ten years after, in such country and in collaboration with public institutions, the first specific law was approved in 1983 (The Orphan Drug Act). The law defined the rare conditions and its treatments: the orphan drugs. After thirty years from this first step, the concept was reinforced in the developed world, and the R&D expansion and investment was six fold increased from basal, especially in the biotechnological area. Afterward LA&C was visualized handed by GEISER Foundation, starting at 2002. Following 8 years of lobbying national laws were incorporated at the official agenda of many LA&C countries. This new scenario in the region validates open debates that facilitate approaching and links in the region. The GEISER Foundation proposal is the translation of the technological management within the region in search of a rationale and a strong unified position, which in turn may provide accessible medical solutions for the people affected by the rare diseases.

Phyllanthus emblica flavonoid glycosides against xanthine oxidase
J. Pharm. Pharmacogn. Res., vol. 12, no. 6, pp. 1067-1078, Nov-Dec 2024. DOI: https://doi.org/10.56499/jppres24.1959_12.6.1067 Original Article Antioxidant potential and xanthine oxidase inhibition of flavonol glycosides from Phyllanthus emblica L. leaves [Potencial antioxidante e inhibición de la xantina oxidasa de los glucósidos de flavonol de las hojas de Phyllanthus emblica L.] Husnunnisa1, Rika Hartati1, Rachmat Mauludin2, … Continue reading Phyllanthus emblica flavonoid glycosides against xanthine oxidase
Spray-drying Perilla frutescens extract optimization
J. Pharm. Pharmacogn. Res., vol. 12, no. 6, pp. 1056-1066, Nov-Dec 2024. DOI: https://doi.org/10.56499/jppres24.2009_12.6.1056 Original Article Optimization of spray-drying conditions and quality assessment of dry extract from Perilla frutescens (L.) Britton leaves [Optimización de las condiciones de secado por atomización y evaluación de la calidad del extracto seco de hojas de Perilla frutescens (L.) Britton] … Continue reading Spray-drying Perilla frutescens extract optimization
Honey clinical applications in complementary medicine
J. Pharm. Pharmacogn. Res., vol. 12, no. 6, pp. 1040-1055, Nov-Dec 2024. DOI: https://doi.org/10.56499/jppres24.1870_12.6.1040 Review Honey clinical applications in complementary medicine: A critical review [Aplicaciones clínicas de la miel en la medicina complementaria: Una revisión crítica] Thai Hau Koo1, Andee Dzulkarnaen Zakaria2*, Mohd Zulkifli Mustafa3 1Department of Internal Medicine, School of Medical Sciences, Universiti Sains … Continue reading Honey clinical applications in complementary medicine

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio